264 related articles for article (PubMed ID: 16897974)
1. [S-1 combined with weekly dosing of cisplatin for metastatic gastric cancer].
Hyodo I
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():64-7. PubMed ID: 16897974
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study.
Tsuji A; Shima Y; Morita S; Uchida M; Okamoto K; Morita M; Horimi T; Shirasaka T
Anticancer Res; 2008; 28(2B):1433-8. PubMed ID: 18505092
[TBL] [Abstract][Full Text] [Related]
3. Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer.
Lee JL; Kang HJ; Kang YK; Ryu MH; Chang HM; Kim TW; Sohn HJ; Kim H; Lee JS
Cancer Chemother Pharmacol; 2008 Apr; 61(5):837-45. PubMed ID: 17579864
[TBL] [Abstract][Full Text] [Related]
4. A phase II multicentric trial of S-1 combined with 24 h-infusion of cisplatin in patients with advanced gastric cancer.
Iwase H; Shimada M; Tsuzuki T; Horiuchi Y; Kumada S; Haruta J; Yamaguchi T; Sugihara M; Ina K; Kusugami K; Goto S
Anticancer Res; 2005; 25(2B):1297-301. PubMed ID: 15865081
[TBL] [Abstract][Full Text] [Related]
5. A phase I study of S-1 administration and a 24-h infusion of cisplatin plus paclitaxel in patients with advanced gastric cancer.
Iwase H; Shimada M; Tsuzuki T; Okeya M; Kobayashi K; Hibino Y; Watanabe H; Goto H
Anticancer Res; 2006; 26(2B):1605-9. PubMed ID: 16619579
[TBL] [Abstract][Full Text] [Related]
6. Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma.
Ajani JA; Faust J; Ikeda K; Yao JC; Anbe H; Carr KL; Houghton M; Urrea P
J Clin Oncol; 2005 Oct; 23(28):6957-65. PubMed ID: 16145066
[TBL] [Abstract][Full Text] [Related]
7. [Combination chemotherapy with tegafur-uracil (UFT) and cisplatin (CDDP) for advanced gastric cancer. UFTP Study Group].
Sato A; Hasegawa K; Kurihara M; Takahashi M; Akazawa S; Fukuyama Y; Koizumi W; Hayakawa M; Sasai T; Kimura K
Gan To Kagaku Ryoho; 1995 Sep; 22(10):1355-62. PubMed ID: 7668870
[TBL] [Abstract][Full Text] [Related]
8. A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method.
Morita S; Nakata B; Tsuji A; Mitachi Y; Shirasaka T; Saji S; Ohashi Y; Sakamoto J; Hirakawa K
Jpn J Clin Oncol; 2007 Dec; 37(12):924-9. PubMed ID: 18211983
[TBL] [Abstract][Full Text] [Related]
9. Phase I study of the sequential administration of S-1 and cisplatin for metastatic gastric cancer.
Baba E; Fujishima H; Kusaba H; Esaki T; Ariyama H; Kato K; Tanaka R; Mitsugi K; Shibata Y; Harada M; Nakano S
Anticancer Res; 2009 May; 29(5):1727-32. PubMed ID: 19443394
[TBL] [Abstract][Full Text] [Related]
10. Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer.
Inada S; Tomidokoro T; Fukunari H; Sato T; Hatano T; Nishimura A; Kawauchi Y; Nikkuni K; Shimizu T; Sato T; Yanagi M; Takahashi S; Yoshida H; Sugita M; Hayashi T
Cancer Chemother Pharmacol; 2009 Jan; 63(2):267-73. PubMed ID: 18379784
[TBL] [Abstract][Full Text] [Related]
11. Phase I study of oral S-1 plus Cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
Kaira K; Sunaga N; Yanagitani N; Kawata T; Utsugi M; Shimizu K; Ebara T; Kawamura H; Nonaka T; Ishikawa H; Sakurai H; Suga T; Hara K; Hisada T; Ishizuka T; Nakano T; Mori M
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):109-14. PubMed ID: 18929446
[TBL] [Abstract][Full Text] [Related]
12. [S-1 combined with weekly paclitaxel in patients with advanced gastric cancer].
Gotoh M; Kawabe S; Takiuchi H
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():91-4. PubMed ID: 16897980
[TBL] [Abstract][Full Text] [Related]
13. [A pilot study of low-dose TS-1 and cisplatin combination chemotherapy for advanced gastric cancer].
Kamata T; Hayashi Y; Minatoya G; Michiwa Y; Onishi I; Takeda T; Koyasaki N; Kanno M
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1419-22. PubMed ID: 11681250
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of combination chemotherapy with S-1 and low-dose cisplatin for highly advanced gastric cancer.
Takahashi T; Saikawa Y; Yoshida M; Kitagawa Y; Otani Y; Kubota T; Kumai K; Kitajima M
Anticancer Res; 2006; 26(2B):1631-5. PubMed ID: 16619584
[TBL] [Abstract][Full Text] [Related]
15. Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma.
Ajani JA; Lee FC; Singh DA; Haller DG; Lenz HJ; Benson AB; Yanagihara R; Phan AT; Yao JC; Strumberg D
J Clin Oncol; 2006 Feb; 24(4):663-7. PubMed ID: 16446338
[TBL] [Abstract][Full Text] [Related]
16. A phase I/II study of S-1 plus cisplatin in patients with advanced gastric cancer: 2-week S-1 administration regimen.
Sato Y; Kondo H; Honda K; Takahari D; Sumiyoshi T; Tsuji Y; Yoshizaki N; Niitsu Y
Int J Clin Oncol; 2005 Feb; 10(1):40-4. PubMed ID: 15729600
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and feasibility of combination chemotherapy with S-1 and cisplatin (2 weeks regimen) for advanced gastric cancer.
Abe S; Tsuji Y; Tsushima T; Kogawa T; Abe M; Onodera Y; Mizushima T; Kukitsu T; Sumiyoshi T; Yoshizaki N; Ishii T; Kondo H
Jpn J Clin Oncol; 2010 Apr; 40(4):302-6. PubMed ID: 20089529
[TBL] [Abstract][Full Text] [Related]
18. Phase I study of S-1 and biweekly docetaxel combination chemotherapy for advanced and recurrent gastric cancer.
Takahashi I; Emi Y; Kakeji Y; Tokunaga E; Ushiro S; Oki E; Watanabe M; Baba H; Maehara Y
Oncol Rep; 2006 Apr; 15(4):849-54. PubMed ID: 16525670
[TBL] [Abstract][Full Text] [Related]
19. A phase I study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 in patients with advanced gastric cancer.
Kimura Y; Yano H; Imamura H; Fujitani K; Imano M; Tokunaga Y; Matsuoka M; Kurokawa Y; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H
Jpn J Clin Oncol; 2013 Feb; 43(2):125-31. PubMed ID: 23225911
[TBL] [Abstract][Full Text] [Related]
20. A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer.
Nakajo A; Hokita S; Ishigami S; Miyazono F; Etoh T; Hamanoue M; Maenohara S; Iwashita T; Komatsu H; Satoh K; Aridome K; Morita S; Natsugoe S; Takiuchi H; Nakano S; Maehara Y; Sakamoto J; Aikou T;
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1103-9. PubMed ID: 18317763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]